Brain Derived Neurotrophic Factor as a Predictor of Response to Treatment in Bipolar Depression and Mania: 16-Weeks Follow-up With Quetiapine XR.
Phase of Trial: Phase III
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Quetiapine (Primary)
- Indications Bipolar I disorders; Mania
- Focus Pharmacogenomic; Therapeutic Use
- 16 Apr 2009 New trial record